article · British Journal of Clinical Pharmacology
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
ALA showed a significant reduction in the severity and delayed the onset of RIOM with a high safety profile through its potent antioxidant effects.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/bcp.70497
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
